# Bacteremia: Interpreting GenMark ePlex® Results – VASP

## Background
-	When BCx turn positive, the lab reports Gram stain and GenMark ePlex® results to help guide empiric therapy, while awaiting further species identification and susceptibilities. 
## Management 
-	Start empiric antibiotic therapy (based on clinical picture and table below)
-	Consider ordering repeat BCx x2 based on organism to document clearance
     -	Repeat for: Staph (MRSA or MSSA), Staph lugdunensis
     -	If source control & no endovascular infx, no need to repeat (most other strep and GNR’s)
-	VUMC antibiograms can be used to reference typical resistance patterns and most common organisms in blood cultures.
-	Candida in a blood culture is NEVER considered a contaminant

## Gram Positive Cocci

Some gram-positive cocci in blood cultures are NEVER considered a contaminant whereas other gram-positive cocci are often contaminants. See algorithm for interpreting GPC in blood cultures on VASP website.

<table border="1">
  <tr>
    <th>Organism</th>
    <th>Resistance Marker</th>
    <th>Preliminary Recommendation</th>
  </tr>
  <tr>
    <td rowspan="2">Staphylococcus aureus<br>or<br>Staphylococcus lugdunensis<br>ID Consult REQUIRED</td>
    <td>mecA detected</td>
        <td>Start vancomycin IV<br></td>
  </tr>
  <tr>
      <td>No mecA detected</td>
    <td>Start nafcillin or cefazolin<br>Stop empiric vancomycin IV</td>
  </tr>
  <tr>
    <td rowspan="2">Staphylococcus epidermidis<br>-Often skin contaminant<br>-Repeat cultures, start therapy if uncertain</td>
    <td>mecA detected</td>
    <td>Start vancomycin IV</td>
  </tr>
  <tr>
      <td>No mecA detected</td>
    <td>Start nafcillin or cefazolin<br>Stop empiric vancomycin IV</td>
  </tr>
  <tr>
    <td>Other coagulase negative Staph<br>-Often skin contaminant<br>-Repeat cultures, start abx if uncertain</td>
    <td></td>
    <td>Start vancomycin IV</td>
  </tr>

  <tr>
    <td>Streptococcus: agalactiae, pyogenes, anginosus</td>
    <td></td>
    <td>Start penicillin IV or CTX IV<br>Stop empiric vancomycin</td>
  </tr>
  <tr>
    <td>Streptococcus pneumoniae</td>
    <td></td>
    <td>Start ceftriaxone<br>Stop empiric vancomycin<br>Await PCN sensitivity data</td>
  </tr>
  <tr>
    <td>Other Streptococcus<br>-May be contaminant</td>
    <td></td>
    <td>Start ceftriaxone<br>Stop empiric vancomycin<br>Await PCN sensitivity data</td>
  </tr>
  <tr>
    <td rowspan="2">Enterococcus faecalis<br>ID Consult REQUIRED</td>
    <td><br>vanA or vanB detected</td>
    <td>Start daptomycin 8-10mg/kg/day IV<br>Don’t treat w vancomycin IV<br>Contact precautions</td>
  </tr>
  <tr>
    <td>No vanA or vanB</td>
    <td>Start ampicillin<br>Stop empiric vancomycin IV</td>
  </tr>
  <tr>
    <td rowspan="2">Enterococcus faecium<br></td>
    <td>vanA or vanB detected</td>
    <td>Start daptomycin 8-10mg/kg/day IV<br>Don’t treat w vancomycin IV<br>Contact precautions</td>
  </tr>
  <tr>
    <td>No vanA or vanB</td>
    <td>Start vancomycin IV<br>Follow-up ampicillin sensitivities</td>
  </tr>
  <tr>
    <td colspan='2'>Micrococcus<br>-Often if in a single blood culture is skin contaminant</td>
        <td>Repeat BCx<br>Start vancomycin IV if uncertain</td>
  </tr>
</table>

## Gram Positive Rods

<table border="1">
  <tr>
    <th>Organism</th>
    <th>Preliminary Recommendation</th>
  </tr>
  <tr>
    <td>Listeria monocytogenes</td>
    <td>Start ampicillin<br>Stop empiric vancomycin IV</td>
  </tr>
  <tr>
    <td>Other Gram positive rod (e.g. Bacillus cereus, Corynebacterium, Cutibacterium acnes, Lactobacillus)<br>-Often skin contaminant<br>-Repeat cultures, start therapy if uncertain<br></td>
    <td>Start vancomycin IV<br>Follow-up sensitivities; some GPRs are resistant to vancomycin</td>
  </tr>
</table>

## Gram Negative Rods
- Consult ID if carbapenem resistance detected

<table border="1">
  <tr>
    <th>Organism</th>
    <th>Preliminary Recommendation</th>
  </tr>
  <tr>
    <td>Acinetobacter baumannii</td>
    <td>Start ampicillin/sulbactam</td>
  </tr>
  <tr>
    <td>Bacteroides fragilis</td>
    <td>Start metronidazole<br>If polymicrobial infection, piperacillin/tazobactam, ampicillin/sulbactam, or meropenem based on other organisms<br>Do NOT double cover anaerobes</td>
  </tr>
  <tr>
      <td>Citrobacter spp.</td>
      <td>Start/continue cefepime</td>
  </tr>
  <tr>
      <td>Cronobacter sakazakii</td>
      <td>Start/continue cefepime</td>
  </tr>
  <tr>
      <td>Enterobacter (non-cloacae complex)</td>
      <td>Start/continue cefepime</td>
  </tr>
  <tr>
      <td>Enterobacter cloacae complex</td>
      <td>Start/continue complex</td>
  </tr>
  <tr>
      <td>Escherichia coli</td>
      <td>Continue empiric coverage and await sensitivities</td>
  </tr>
  <tr>
      <td>Fusobacterium nucleatum<br>Fusobacterium necrophrum</td>
      <td>Start ampicillin/sulbactam or start/continue metronidazole</td>
  </tr>
  <tr>
      <td>Haemophilus influenzae</td>
      <td>Start/continue ceftriaxone</td>
  </tr>
  <tr>
      <td>Klebsiella oxytoca</td>
      <td>Continue empiric coverage and await sensitivities</td>
  </tr>
  <tr>
      <td>Klebsiella pneumoniae group</td>
      <td>Continue empiric coverage and await sensitivities</td>
  </tr>
  <tr>
      <td>Morganella morganii</td>
      <td>Start/continue cefepime</td>
  </tr>
  <tr>
      <td>Neisseria meningitidis</td>
      <td>Continue empiric coverage and await sensitivities</td>
  </tr>
  <tr>
      <td>Proteus spp.<br>Proteus mirabilis</td>
      <td>Continue empiric coverage and await sensitivities</td>
  </tr>
  <tr><td>Pseudomonas aeruginosa</td><td>Start/continue cefepime or piperacillin-tazobactam</td></tr>
  <tr>
      <td>Salmonella spp</td>
      <td>Start/continue ceftriaxone</td>
  </tr>
  <tr>
      <td>Serratia spp.<br>Serratia marcescens</td>
      <td>Start/continue cefepime</td>
  </tr>
  <tr>
      <td>Stenotrophomonas maltophiolia</td>
      <td>Start trimethoprim-sulfamethoxazole (15-20mg/kg/day divided q8h for normal renal function)</td>
  </tr>
  <tr>
      <th colspan='2'><b>Gram-Negative Resistance Genes</b></th>
  </tr>
  <tr>
      <td>CTX-M Positive (ESBL)</td>
      <td>Start meropenem<br>Consider an infectious diseases consult<br>Contact precautions (see infection prevention website)</td>
  </tr>
  <tr>
      <td>IMP positive<br>KPC positive<br>NDM positive<br>OXA (OXA-23 and OXA-48) positive<br>VIM positive</td>
      <td>Carbapenemase-producing organism<br>Obtain infectious disease consultation<br>Contact precautions (see infection prevention website)</td>
  </tr>
</table>
